Improve Heart Health With Vitamin K2

Have you ever met someone who takes their medication, eats well, exercises regularly — and still ends up with heart disease? I have. In 25 years as a registered dietitian, I’ve sat across from patients who were doing everything “right” and still watching their arteries calcify, their blood pressure creep up, and their cardiologist schedule another procedure.

One nutrient I keep coming back to in these conversations is vitamin K2. It is not trendy. It doesn’t show up in multivitamins in meaningful doses. Most clinicians never mention it. And yet the research — particularly new trials published in 2025 and 2026 — is among the most compelling I’ve seen for any single nutrient and cardiovascular risk.

This post covers everything you need to know about vitamin K2 and heart health, updated with the latest science.

Vitamin K2 and Heart Health: The Overview

Vitamin K2 is a fat-soluble vitamin that most people have never heard of — yet research links it to a reduced risk of coronary heart disease and lower heart disease mortality. Most Western adults have undetectable levels of K2 in their blood. Cholesterol-lowering statins may interfere with it. And the medical establishment rarely tests for it.

The mechanism is elegant: vitamin K2 activates a set of proteins — particularly matrix GLA protein (MGP) — that essentially act as traffic cops for calcium. When K2 is present, calcium gets routed to bones and teeth. When K2 is absent, calcium ends up where you absolutely don’t want it: depositing in artery walls, stiffening vessels, and setting the stage for heart attacks and strokes.

This matters enormously for anyone on supplemental vitamin D — because vitamin D increases calcium absorption, which means the demand for K2 rises. More on cofactors below.

Why Vitamin K2 Deficiency Is So Common

Based on typical Western food intake, roughly 97% of people are vitamin K2 deficient. Here’s why this number is so high:

• The best food source — natto (fermented soybeans) — is rarely eaten in Western countries
• K2 content in cheese varies wildly depending on region, processing, and moisture content (research)
• Grass-fed animal products contain modest K2; conventional grain-fed products contain almost none
• The following conditions and medications deplete K2 further: antibiotics, bile acid sequestrants, fat-blocking supplements, obesity, GI and liver diseases

The ideal daily intake for cardiovascular benefit appears to be at least 35–180 mcg of MK-7 per day. To get 35 mcg from food alone, you’d need to eat roughly a quarter pound of cheese every single day — and you still couldn’t be sure the variety you chose had adequate amounts. Supplementation is, for most people, the most reliable approach.

For a deeper dive into the K1 vs. K2 distinction, see my post on the differences between vitamin K1 and vitamin K2.

How Vitamin K2 Strengthens the Heart

The process of carboxylation — how vitamin K activates proteins — is central to almost everything K2 does in cardiovascular tissue. When K2 is present in sufficient amounts, it carboxylates (activates) proteins including:

• Matrix GLA protein (MGP): Blocks calcium from depositing in artery walls
• Osteocalcin: Guides calcium into bone; also influences insulin sensitivity and adiposity (more below)
• Gas6: Involved in vascular cell survival and inflammation regulation

Clinical evidence shows that vitamin K2 supplementation can:

• Reduce progression of coronary artery calcification (CAC) — the newest RCT data show a 22% arrest in CAC progression
• Decrease arterial stiffness as measured by pulse-wave velocity
• Reduce inflammation markers including TNF-α and interleukins
• Lower diabetes risk by approximately 5% per 10 mcg increase in daily K2 intake
• Support mitochondrial energy production in heart and skeletal muscle cells
• Improve body composition, including visceral fat reduction

Vitamin K2 Reduces Heart Disease Risk

The landmark Rotterdam Study followed 4,807 patients for over seven years. Those with the highest dietary vitamin K2 intake had a 57% reduced risk of dying from heart disease and significantly less coronary calcification. Crucially, the results were dose-dependent — the more K2, the stronger the protection. The protective intake threshold was approximately 32 mcg per day.

The large Prospect-EPIC Study of postmenopausal women confirmed similar findings: higher K2 intake was associated with meaningfully reduced coronary calcification — while vitamin K1 showed no such benefit. This is a critical distinction. Vitamin K2, not K1, is the form that protects arteries.

The Danish Diet, Cancer and Health Study — following 53,372 people for 21 years — found that the highest vitamin K2 consumers had a 14% lower risk of atherosclerotic cardiovascular disease hospitalizations. That’s a substantial public health impact from a single nutrient most people aren’t getting.

Breakthrough 2025 Trial: Vitamin K2 Arrests Coronary Artery Calcification

The most significant heart health news for vitamin K2 in years came from the VitaK-CAC Trial, presented at the 34th European Meeting on Hypertension and Cardiovascular Protection in May 2025. This was a double-blind, randomized, placebo-controlled trial in patients with pre-existing coronary artery calcification (CAC scores 50–400 Agatston units).

After two years of supplementation with 360 mcg/day of MK-7 (MenaQ7), the progression of coronary artery calcification was arrested by 22% compared to placebo — regardless of blood pressure status. Participants also showed increased MGP activation and higher circulating vitamin K2 levels.

This is clinically meaningful because CAC score progression is one of the strongest independent predictors of heart attack and cardiovascular mortality. Slowing that progression is one of the few modifiable interventions shown to work.

Clinical perspective: I’ve seen clients in my practice with elevated CAC scores who feel powerless after the test. The VitaK-CAC data provides real hope — and a concrete nutritional intervention strategy — for people who have already accumulated some calcification. This is the kind of result that changes how I counsel clients about supplementation.

Vitamin K2 Improves Artery Flexibility and Function

A groundbreaking three-year randomized controlled trial enrolled 244 postmenopausal women who received either 180 mcg/day of MK-7 (MenaQ7) or placebo. Women supplementing with K2 showed significantly reduced arterial stiffness compared to placebo — measured by both ultrasound and pulse-wave velocity (validated clinical tools).

The effects were most pronounced in women who started with the worst artery function. Arterial stiffness is a direct predictor of future heart attacks, coronary artery disease severity, and death. Improving it is one of the most important things a person can do for long-term heart health.

A 2025 post-hoc analysis of the one-year MenaQ7 study confirmed for the first time that K2 supplementation also significantly reduced vascular stiffness and improved blood pressure in postmenopausal women — a new and meaningful finding.

Vitamin K2 Reduces Cardiovascular Inflammation

Chronic low-grade inflammation is now considered the underlying driver of nearly all cardiovascular disease. It’s the smoldering fire beneath the surface of arterial plaques, metabolic dysfunction, and clot formation.

Cell research demonstrates that pure MK-7 reduces inflammation markers including TNF-α, IL-1α, and IL-1β gene expression and protein production in a dose-dependent manner. Population-level data echo this — the large Dutch cohort study (nearly 40,000 participants) found that higher K2 intake correlated with lower C-reactive protein (CRP), a key marker of systemic inflammation.

For my clients dealing with elevated CRP or other inflammatory markers alongside cardiovascular risk, K2 is one of the nutrients I revisit in the context of broader anti-inflammatory support — alongside magnesium, omega-3s, and dietary pattern changes.

Vitamin K2 Reduces Diabetes Risk — A Heart Connection

Heart disease and type 2 diabetes are deeply intertwined. In a large observational study of nearly 40,000 people followed for 10 years, vitamin K2 reduced diabetes risk by approximately 5% for every 10 mcg increase in daily intake. The same study found reductions in C-reactive protein.

The mechanism involves osteocalcin, a vitamin K-dependent protein that — when activated — helps regulate insulin secretion and sensitivity. MK-7 also improves insulin sensitivity through multiple additional pathways: gut microbiome modulation, mitochondrial function enhancement via the SIRT1 signaling pathway, and enhanced fatty acid beta-oxidation.

Reducing diabetes risk is one of the most direct ways to reduce cardiovascular disease risk — the two conditions share most of the same root mechanisms.

New 2026 Research: Vitamin K2 and Body Composition

A May 2026 randomized controlled trial published in Nutrients by Bittner, de Vries, Schurgers et al. adds a compelling new dimension to the K2 story. The study enrolled 243 adults (166 women, 77 men) with low vitamin K2 status, who received 180 mcg MK-7 daily for one year.

Key findings:

• Low vitamin K2 status was significantly associated with higher BMI, visceral adipose tissue (VAT), and fat mass index at baseline
• After one year, the entire group showed a small but statistically significant BMI reduction of 0.66%
• “High responders” — those who achieved the greatest K2 status improvement — showed fat mass decreasing by nearly 2%, waist-to-hip ratio dropping by 1.43%, BMI falling by 1.37%, and weight declining by 1.25%
• Non-responders actually saw visceral fat increase by over 7%, underscoring the importance of achieving adequate K2 status
• Women — especially premenopausal women — showed the greatest benefits, with 90.9% of women achieving significant K2 status improvement

This research matters for heart health because visceral fat is an independent cardiovascular risk factor. Reducing it — without changing diet or exercise — through K2 optimization is a remarkable finding that warrants wider attention.

The proposed mechanism involves ferroptosis regulation. Ferroptosis Suppressor Protein 1 (FSP1) — a recently discovered protein in the vitamin K cycle — is highly expressed in adipose tissue. K2 supplementation appears to modulate FSP1 activity, potentially reducing adipose tissue accumulation through this novel pathway.

Vitamin K2 Supports Heart Energy Production

The heart is the most metabolically demanding organ in the body. It beats over 100,000 times a day and never gets a rest. All of that work depends on robust mitochondrial function.

Vitamin K2 participates directly in mitochondrial electron transport — the process that generates ATP (cellular energy). It also protects mitochondria from oxidative damage and supports mitochondrial biogenesis through the SIRT1 signaling pathway.

In a cell study, K2 supplementation increased both the number of mitochondria and the regenerative capacity of skeletal muscle cells. The parallel in heart muscle is compelling: diseased hearts are characterized by reduced mitochondrial function and numbers. Vitamin K2 may help maintain the mitochondrial health the heart depends on.

This connects to broader mitochondrial support strategies I discuss in my clinical work — where nutrients like CoQ10, B vitamins, and K2 work synergistically to sustain cardiovascular energy production.

Cofactors That Work With Vitamin K2 for Heart Health

No nutrient works in isolation. For vitamin K2 to work optimally for heart health, several cofactors matter:

• Vitamin D3: Vitamin D upregulates calcium absorption — which increases the demand for K2 to properly direct that calcium away from arteries and into bone. If you’re supplementing vitamin D without K2, you may be inadvertently increasing arterial calcium risk. Many experts recommend combining them.
• Magnesium: Essential for over 300 enzyme reactions, including those governing vascular smooth muscle function, blood pressure regulation, and energy production. My post on magnesium goes deep on this. Most Americans are deficient in magnesium as well.
• CoQ10: Works alongside K2 in the mitochondrial electron transport chain. Both nutrients decline with age. Statins deplete CoQ10 directly — and as noted, may also interfere with vitamin K2. If you’re on a statin, both K2 and CoQ10 deserve attention.
• Omega-3 fatty acids: Anti-inflammatory, triglyceride-lowering, and supportive of artery wall integrity — a natural complement to K2’s anti-calcification actions.

How to Choose and Use a Vitamin K2 Supplement

Not all vitamin K2 supplements are equal. The form matters enormously:

• The natural all-trans MK-7 form is the most bioavailable and the most studied for cardiovascular benefit
• The cis-form of MK-7 is only about 10% as biologically active as the all-trans form
• Some synthetic forms are completely inactive
• MenaQ7 (from Nattopharma/Gnosis by Lesaffre) is the form used in the majority of the clinical trials cited in this post — it is allergen-free and derived from chickpea fermentation

For dosing: most cardiovascular studies used 180–360 mcg/day of MK-7. At minimum, 100 mcg/day is a reasonable starting point. Higher doses (360 mcg/day) were used in the VitaK-CAC trial for existing coronary artery calcification.

See my in-depth guide on the best vitamin K2 supplement brands for specific product recommendations and what to look for on labels.

Medication Interactions and Safety

Vitamin K2 is remarkably safe — no toxicity has been observed even at very high doses in research settings. However, there are important interactions to know:

• Warfarin (Coumadin): Do not add vitamin K2 without medical supervision. Your provider will need to monitor your INR closely. Lower doses (45–100 mcg) can sometimes be used safely, but this requires clinical oversight.
• Statins: These may interfere with vitamin K2 metabolism — an underappreciated interaction. The observation that warfarin patients needed less warfarin when on statins was an early clue. If you’re on a statin, ask your provider about K2.
• Newer anticoagulants (Eliquis, Xarelto, Pradaxa): These generally do not interact with vitamin K.

The following conditions and medications also deplete or impair vitamin K2 status:

• Antibiotics (kill gut bacteria that produce some K2)
• Dilantin and other anti-seizure medications
• Estrogen drugs
• Bile acid sequestrants: cholestyramine, colestipol, colesevelam, Orlistat, Xenical
• Mineral oil
• Obesity (K2 gets sequestered in adipose tissue)
• GI tract and liver diseases
• A preservative called butylated hydroxytoluene (BHT)

Always discuss supplementation with your healthcare provider, especially if you have cardiovascular disease or take any of the above medications. For more on choosing the best supplement brands, I’ve covered the key quality factors in detail.

A Clinical Dietitian’s Personal Perspective on Vitamin K2

I have been recommending vitamin K2 to appropriate clients for well over a decade. Here’s what I’ve observed in practice, and why I think it’s one of the most underutilized nutrients in cardiovascular prevention:

The clients who stand out most in my memory are people on long-term warfarin therapy who come in after a routine DEXA scan showing significant arterial calcification. Their cardiologists are often focused on statin optimization and blood pressure management — both important — but the nutrient depletions caused by warfarin itself (and by the statins many are also taking) rarely get addressed.

When I first started reviewing the Rotterdam Study data, the dose-response relationship between K2 and cardiovascular mortality struck me as one of the cleanest nutrition-cardiac associations I’d seen. A 57% reduction in cardiac mortality in the highest K2 tertile isn’t subtle. And unlike so many “promising” nutrition findings that evaporate when replicated, K2 has held up across multiple large cohorts and multiple mechanistic pathways.

The 2026 body composition data from Bittner et al. added another piece I hadn’t fully appreciated: K2 deficiency isn’t just a heart issue — it’s intertwined with metabolic health, adiposity, and inflammatory status in a way that makes it a genuine whole-body nutrient.

I’m not claiming K2 replaces medication or is appropriate for everyone. I’m saying that for the majority of Western adults, it is a gap worth filling — with a good-quality, all-trans MK-7 supplement at an evidence-based dose.

Frequently Asked Questions About Vitamin K2 and Heart Health

How does vitamin K2 protect the heart?

Vitamin K2 activates matrix GLA protein (MGP), which prevents calcium from depositing in artery walls — the primary driver of arterial stiffness and calcification. It also reduces inflammation, supports mitochondrial energy production in cardiac cells, improves insulin sensitivity, and (per 2026 research) helps reduce visceral fat — all of which are cardiovascular risk factors.

What is the best dose of vitamin K2 for heart health?

Clinical trials show benefits starting at 180 mcg/day of MK-7. The VitaK-CAC trial used 360 mcg/day and demonstrated a 22% arrest in coronary artery calcification progression over two years. For general cardiovascular prevention, 100–200 mcg/day of all-trans MK-7 is a reasonable starting point.

Can I get enough vitamin K2 from food?

Very unlikely if you live in the West. Natto is the only food with reliably high amounts. Cheese and egg yolks contain modest amounts. Given the inconsistency of food sources and the prevalence of conditions that deplete K2, supplementation is the most reliable strategy for most people.

Is vitamin K2 safe with blood pressure medications?

Yes, K2 does not generally interact with blood pressure medications. It interacts primarily with vitamin K antagonists like warfarin. Most other medications — including most blood pressure drugs — are safe to combine with K2. Always confirm with your prescribing provider.

What nutrients work with vitamin K2 for heart health?

Vitamin D3 (paired with K2 to direct calcium properly), magnesium (critical for vascular function), CoQ10 (mitochondrial energy in heart cells), and omega-3 fatty acids all work synergistically with K2 for cardiovascular support.

Does vitamin K2 help with body weight and visceral fat?

A 2026 randomized controlled trial found that adults with low vitamin K2 status had significantly higher BMI, visceral fat, and fat mass. After one year of MK-7 supplementation, responders — especially premenopausal women — showed meaningful reductions in all these measures without any dietary or exercise intervention.

Heidi Moretti, MS, RD, CLT

Heidi is a registered dietitian with 25+ years of clinical experience specializing in functional nutrition, gut health, and natural medicine. She is the author of Cortisol Fix, Period Fix, Gut Fix, and The Whole Body Guide to Gut Health, and runs The Healthy RD and her clinical practice Align Wellness in Missoula, Montana.